Viehbacher
Former Sanofi chief executive joins Waypoint
June 23, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Viehbacher, waypoint
The former Sanofi chief executive Christopher Viehbacher is joining Geneva-headquartered business enterprise firm Waypoint Capital as a managing partner.
Ousted Sanofi boss finds role at PureTech
February 27, 2015Sales and Marketing Bayer, Sanofi, Viehbacher, baumann, brandicourt, pott, puretech
US science and technology R&D company PureTech has appointed the former Sanofi chief executive Christopher Viehbacher to its board. Viehbacher …
Sanofi looking to diversify, may buy into animal health
December 11, 2014Manufacturing and Production, Research and Development, Sales and Marketing EFPIA, Jimenez, Sanofi, Serge Weinberg, Viehbacher, animal health
Sanofi is looking to diversify and is even considering buying into the consumer and animal health markets according to its …
Sanofi cuts earnings guidance despite return to sales growth
October 31, 2013Sales and Marketing Sanofi, Viehbacher, vaccines
Sanofi cut its earnings guidance for 2013 after its third quarter results missed targets, despite a return – barely – …
Sanofi chief executive to lead EFPIA
June 26, 2013Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty
Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …
Sanofi won’t follow trend for spin-offs
February 8, 2013Sales and Marketing Abbott, Pfizer, Sanofi, Viehbacher
Sanofi’s chief executive Chris Viehbacher says the firm plans to maintain its portfolio of business divisions for the foreseeable future, …
More job cuts planned at Sanofi, says union
July 6, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Viehbacher, cuts
Sanofi has confirmed that it is considering a restructuring of its operations in France, but has refused to comment on …
